Sutro Biopharma Ownership | Who Owns Sutro Biopharma?


Sutro Biopharma Ownership Summary


Sutro Biopharma is owned by 77.34% institutional investors, 0.94% insiders, and 21.73% retail investors. Blackrock is the largest institutional shareholder, holding 11.24% of STRO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.93% of its assets in Sutro Biopharma shares.

STRO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSutro Biopharma77.34%0.94%21.73%
SectorHealthcare Stocks 56.95%9.26%33.79%
IndustryBiotech Stocks 68.60%8.88%22.52%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock6.91M11.24%$20.25M
Blackrock funding, inc. /de7.59M9.26%$13.97M
Suvretta capital management7.46M9.10%$13.73M
Vanguard group4.21M5.13%$7.74M
Kynam capital management, lp3.64M4.44%$6.70M
Merck2.72M3.32%$5.01M
Vestal point capital, lp2.57M3.13%$4.73M
Point72 asset management2.20M2.68%$4.04M
Samsara biocapital2.20M2.68%$4.04M
Bioimpact capital2.16M2.63%$3.97M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Merck2.72M1.94%$5.01M
Bioimpact capital2.16M0.56%$3.97M
Samsara biocapital2.20M0.55%$4.04M
Suvretta capital management7.46M0.47%$13.73M
Parkman healthcare partners1.73M0.42%$3.18M
Kynam capital management, lp3.64M0.40%$6.70M
Vestal point capital, lp2.57M0.28%$4.73M
Dafna capital management437.08K0.20%$804.23K
Eversept partners, lp694.41K0.11%$1.28M
Shay capital203.60K0.06%$374.63K

Top Buyers

HolderShares% AssetsChange
Merck2.72M1.94%2.72M
Vestal point capital, lp2.57M0.28%2.57M
Kynam capital management, lp3.64M0.40%1.57M
Blackrock6.91M0.00%1.21M
Blackrock funding, inc. /de7.59M0.00%577.07K

Top Sellers

HolderShares% AssetsChange
Millennium management405.62K0.00%-1.63M
Baillie gifford48.79K0.00%-1.47M
Eversept partners, lp694.41K0.11%-1.15M
Bank of montreal /can/---814.96K
Point72 asset management2.20M0.01%-799.91K

New Positions

HolderShares% AssetsChangeValue
Merck2.72M1.94%2.72M$5.01M
Vestal point capital, lp2.57M0.28%2.57M$4.73M
Lpl financial230.15K0.00%230.15K$674.34K
Shay capital203.60K0.06%203.60K$374.63K
Thrivent financial for lutherans97.10K0.00%97.10K$178.00K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-13.00
Allspring global investments-15.00
Us bancorp \de\-53.00
Signaturefd-86.00
Rothschild investment-200.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024121-9.70%63,450,8221.49%771.33%62-15.07%359.38%
Sep 30, 20241339.02%62,516,015-1.03%761.26%73-7.59%3110.71%
Jun 30, 20241223.39%63,167,39418.26%771.03%7916.18%28-12.50%
Mar 31, 20241183.51%53,412,278-3.97%861.05%6811.48%3210.34%
Dec 31, 20231143.64%55,621,581-0.54%911.07%6122.00%29-12.12%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.42M2.93%-
iShares Russell 2000 ETF2.21M2.68%-16.80K
Vanguard Institutional Extnd Mkt Idx Tr1.19M1.44%-
CREF Stock R11.03M1.25%-
Baillie Gifford Global Discovery A Acc904.60K1.10%-13.25K
Fidelity Small Cap Index839.59K1.02%6.39K
iShares Russell 2000 Value ETF752.65K0.91%1.02K
Edinburgh Worldwide Ord555.93K0.67%-194.80K
State St Russell Sm/Mid Cp® Indx NL Cl C502.75K0.61%-
iShares Biotechnology ETF479.20K0.58%-1.02K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 29, 2024Vasquez Nicki CHIEF PORT. STRAT & ALNCE OFCRSell$60.92K
Aug 28, 2023Shtylla Brunilda Chief Business OfficerSell$72.59K
Aug 25, 2023Shtylla Brunilda Chief Business OfficerSell$53.28K
Mar 14, 2022NEWELL WILLIAM J CEOBuy$77.51K
Sep 28, 2021Vasquez Nicki Chief Port. Strat & Alnce OfcrSell$72.72K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1-1
2023 Q4--

STRO Ownership FAQ


Who Owns Sutro Biopharma?

Sutro Biopharma shareholders are primarily institutional investors at 77.34%, followed by 0.94% insiders and 21.72% retail investors. The average institutional ownership in Sutro Biopharma's industry, Biotech Stocks , is 68.60%, which Sutro Biopharma exceeds.

Who owns the most shares of Sutro Biopharma?

Sutro Biopharma’s largest shareholders are Blackrock (6.91M shares, 11.24%), Blackrock funding, inc. /de (7.59M shares, 9.26%), and Suvretta capital management (7.46M shares, 9.10%). Together, they hold 29.60% of Sutro Biopharma’s total shares outstanding.

Does Blackrock own Sutro Biopharma?

Yes, BlackRock owns 11.24% of Sutro Biopharma, totaling 6.91M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 20.25M$. In the last quarter, BlackRock increased its holdings by 1.21M shares, a 21.20% change.

Who is Sutro Biopharma’s biggest shareholder by percentage of total assets invested?

Merck is Sutro Biopharma’s biggest shareholder by percentage of total assets invested, with 1.94% of its assets in 2.72M Sutro Biopharma shares, valued at 5.01M$.

Who is the top mutual fund holder of Sutro Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Sutro Biopharma shares, with 2.93% of its total shares outstanding invested in 2.42M Sutro Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools